Unigen
Unigen, Inc. is a privately held botanical-ingredient company that discovers, patents, and clinically validates proprietary plant-derived actives for nutraceutical, cosmeceutical, and companion-animal supplement manufacturers, commercializing them globally through licensing and supply alliances via a 15+ partner distributor network.
- Company typePrivate
- Founded1996
- HeadquartersTacoma, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Unigen does
Unigen, Inc. is a privately held botanical-ingredient research and development company founded in 1995 and headquartered in Tacoma, Washington. The company discovers, patents, clinically validates, and commercializes proprietary plant-derived actives for use in three downstream markets: human nutraceuticals (joint health, immune support, sleep, metabolism, respiratory, and skin), cosmeceuticals (anti-acne, hyperpigmentation, photoaging, barrier repair, brightening), and companion-animal supplements (joint, oral, immune, skin, and stress/anxiety support). Branded ingredients include Univestin®, Maizinol®, Symetrian™, Loesyn™, AmLexin®, Bakutrol®, FeraLuxe™, GinSTEM™, Lumicyn™ Pure, Soliprin™, and the Symetrian™/Maizinol® Pet Health variants.
The company's core technical asset is PhytoLogix®, a proprietary research platform integrating bioprospecting, bioinformatics, high-throughput purification, and structure dereplication across a library of more than 11,000 documented medicinal plants, 600+ marine collections, 15,000+ extracts, 300,000+ HTP fractions, and a structure database of 170,000+ natural products from 24 countries. In June 2023, Unigen added Phyto-AI™, an AI/ML-enabled informatics layer built with Vestrics Solutions, currently in phased rollout intended to enable machine learning mining of historical, safety, and regulatory data. Each ingredient is supported by peer-reviewed, randomized clinical trial data (published in journals including PLOS ONE, Frontiers in Nutrition, Food Science and Nutrition, Journal of Dermatology) and, where applicable, issued patents in major territories (e.g., 17 issued patents covering Bakutrol®).
Unigen operates an exclusively B2B, asset-light ingredient-licensing and ingredient-supply model. It does not sell finished consumer products; instead it supplies its patented actives — supported by clinical claim packages and marketing collateral — to nutraceutical, cosmeceutical, and pet-health manufacturers via a global network of 15+ regional distributors (including LEHVOSS Nutrition in Europe, Viridis BioPharma/Personal Care in India, Science Based Ingredients in Canada, Ayalla in Brazil, CIC Frontier and Daiwa in Japan, CTC Group in the Philippines, Lehvoss Cosmetics in Germany, and Zeal in China, among others) and through direct ingredient supply alliances with brands such as GHOST® Lifestyle (GHOST® JOINT with Univestin®) and DaVinci® Laboratories (Sleep Benefits™ Melatonin Free with Maizinol®). Pricing is quote-based and not publicly disclosed, and manufacturing is performed internally to GMP standards. The company employs 101–250 staff and has served the industry continuously for 30 years.
Unigen firmographics
Firmographics- Name
- Unigen
- Legal name
- Unigen, Inc.
- Website
- https://unigen.net
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Unigen, Inc. is a privately held botanical-ingredient company that discovers, patents, and clinically validates proprietary plant-derived actives for nutraceutical, cosmeceutical, and companion-animal supplement manufacturers, commercializing them globally through licensing and supply alliances via a 15+ partner distributor network.
- Ownership category
- akta.pro rank
Unigen industry classification
Industry- Product category
- Botanical Ingredients
- NAICS
- Medicinal and Botanical Manufacturing (325411), Dog and Cat Food Manufacturing (311111)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Herbal & Botanical Supplements (CRADAGAD)
- akta.pro secondary industries
- Natural Extracts & Essential Oils (Botanical/Citrus/Herb/Spice Extracts) (AFAJADAB), Flavorings & Extracts (Natural & Artificial) (CRADAOAA), Manufacturing, Private Label & Co-Manufacturing for Animal Diets (HLAMAHAO), Natural/Organic & Limited-Ingredient Diets (CRADAFAH)
Keywords
Where Unigen is headquartered
LocationHeadquarters
- HQ city
- Tacoma
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Unigen business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Ingredient Licensing and Supply: Unigen commercializes its proprietary patented botanical ingredients through licensing agreements and ingredient supply alliances with commercial partners engaged in the manufacture, distribution, and marketing of end-products in nutraceutical, cosmeceutical, pharmaceutical, and pet health markets. The company manufactures its products to GMP standards.
- Ingredient Supply Agreements: Direct supply of proprietary branded botanical ingredients (nutraceuticals, cosmeceuticals, pet health) to commercial partners who incorporate them into finished consumer products. Ingredients are supplied under supply alliances with ingredient pricing and MOQ requirements.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels7 records
Unigen product offering
Product offeringCore offering
Unigen develops proprietary patented botanical extracts through its PhytoLogix® research platform and commercializes them as branded ingredients to B2B manufacturers across three product lines: Nutraceuticals (human dietary supplement actives), Cosmeceuticals (skin and hair care actives), and Pet Health (companion animal wellness actives). Ingredients are clinically validated, manufactured to GMP standards, protected by issued patents in all major territories, and supplied under licensing and ingredient supply alliances to commercial partners that formulate finished consumer products.
Product overview
Unigen develops patented botanical extracts through its proprietary PhytoLogix® research platform for use as novel ingredients in nutraceutical, cosmeceutical, and pharmaceutical products. The product portfolio spans three categories: (1) Nutraceuticals - human health ingredients including AmLexin®, ArthroLexin™, Attenutin™, Lasoperin™, Loesyn™, Maizinol®, Sebatin™, Symetrian™, and Univestin® targeting joint health, immune support, sleep, metabolism, and respiratory wellness; (2) Cosmeceuticals (Unigen Beauty) - clinically proven skin and hair care active ingredients including Bakutrol® A, FeraLuxe™, Flavonique™, GinSTEM™, Lumicyn™ Pure, and Soliprin™; (3) Pet Health - companion animal wellness ingredients including AmLexin® for Pets, Anivestin® for Pets, Oravestin™ for Pets, Peroflav™ for Pets, Symetrian™ for Pets, SerenZea™ for Pets, and Uniflavon® for Pets. Unigen commercializes its proprietary ingredients through licensing and ingredient supply alliances with commercial partners.
Differentiator
Problem solved
Functional benefit
Brands
- Unigen Beauty: Cosmeceutical ingredient division comprised of clinically proven, patented, naturally derived active ingredients for skin and hair care products.
- Unigen Pet Health
- PhytoLogix®
Products and services
- AmLexin® Joint health ingredient combining Morus alba root bark and Acacia catechu heartwood, clinically shown to support cartilage health and diminish post-exercise discomfort. For B2B nutraceutical manufacturers.
- ArthroLexin™ Joint health ingredient for supporting joint comfort and mobility. For B2B nutraceutical manufacturers.
- Attenutin™ Respiratory support ingredient with published pre-clinical research on efficacy in attenuating acute inflammatory lung injury and sepsis. For B2B nutraceutical manufacturers.
- Lasoperin™ Nutraceutical ingredient for immune and respiratory support. For B2B nutraceutical manufacturers.
- Loesyn™ Metabolism support ingredient clinically proven to maintain healthy glucose levels, support normal insulin sensitivity, and reduce oxidative stress. For B2B nutraceutical manufacturers.
- Maizinol® Hormone-free, standardized corn leaf extract for sleep support with a triple-action mechanism: supporting natural melatonin production, upregulating MT1/MT2 receptors, and direct receptor binding. Clinically shown to improve deep sleep quality and increase sleep duration. For B2B nutraceutical manufacturers.
- Sebatin™ Nutraceutical ingredient for skin and sebum health support. For B2B nutraceutical manufacturers.
- Symetrian™ Immune support ingredient — synergistic blend of Poria Cocos mushroom, Aloe, and Rosmarinic Acid. Clinically proven to selectively increase TCRγδ+ Gamma delta T cells, activate innate immunity within 1 hour and adaptive immunity within 3 hours. For B2B nutraceutical manufacturers.
- Univestin® Premier joint health ingredient clinically proven to provide support as fast as 3 days, promote joint comfort within 5 days, and support range of motion within 7 days. For B2B nutraceutical manufacturers.
- Bakutrol® A Ultra-pure Bakuchiol (Hydrolyzed Psoralea Corylifolia extract) with minimum 60% Bakuchiol content, processed to remove all phytotoxins. Clinically proven for potent blemish control with triple function as broad-spectrum antimicrobial, potent antioxidant, and anti-inflammatory agent. For B2B cosmeceutical manufacturers.
- FeraLuxe™ Natural solution for photoaging, providing anti-aging benefits for skin exposed to UV radiation. For B2B cosmeceutical manufacturers.
- Flavonique™ Treatment for dry, itchy, and patchy skin from a compromised barrier, targeting skin discomfort and barrier repair. For B2B cosmeceutical manufacturers.
- GinSTEM™ Panax Ginseng Stem Cell Lysate with Exosomes for skin and hair renewal applications. For B2B cosmeceutical manufacturers.
- Lumicyn™ Pure Brightening and calming solution to improve uneven skin tone induced by hyperpigmentation. ECOCERT COSMOS Approved. For B2B cosmeceutical manufacturers.
- Soliprin™ Solution for premature skin aging induced by external exposome (environmental factors), protecting skin from environmental damage. For B2B cosmeceutical manufacturers.
- AmLexin® for Pets Specialized blend of Morus alba and Acacia catechu supporting cartilage health and diminishing post-exercise discomfort in companion animals. For B2B pet supplement manufacturers.
- Anivestin® for Pets Joint and mobility support ingredient derived from Scutellaria baicalensis and Acacia catechu, enriched for bioflavonoids to address joint discomfort in pets. For B2B pet supplement manufacturers.
- Oravestin™ for Pets Oral wellness ingredient derived from Scutellaria baicalensis roots and Acacia catechu heartwoods, addressing both bacterial growth and inflammation for lasting oral health in pets. For B2B pet supplement manufacturers.
- Peroflav™ for Pets Skin health ingredient providing pet-approved dry skin relief and itchiness reduction for companion animals. For B2B pet supplement manufacturers.
- Symetrian™ for Pets Immune support ingredient for companion animals, providing similar immune defense benefits as the human formula. For B2B pet supplement manufacturers.
- SerenZea™ for Pets Hormone-free, non-GMO, plant-derived ingredient from corn leaves (Zea mays) offering natural stress and anxiety relief for pets by reducing stress markers and promoting positive mood balance. For B2B pet supplement manufacturers.
- Uniflavon® for Pets Skeletal health ingredient from Scutellaria baicalensis and Phyllostachys pubescens extracts targeting dry skin relief and itchiness in companion animals. For B2B pet supplement manufacturers.
- PhytoLogix® Platform Proprietary research technology platform enabling high-throughput screening of ethnomedicinal plants for predictive discovery of novel natural actives for nutritional, cosmeceutical, and pharmaceutical applications.
- Phyto-AI™ Database Proprietary AI/ML-enabled informatic system that enhances the PhytoLogix® platform by mining historical usage, modern research, safety, and regulatory data for accelerated natural ingredient discovery and reduced time to market.
Quantifiable outcome
- Maizinol® clinically shown to improve quality of deep sleep by up to 49%
- +6 more outcomes
Companies that use Unigen
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Unigen technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Unigen partnerships and signals
Strategic signalPartnerships
20 partnerships are on record, tiered core and secondary.
- GHOST LifestylecoreUnigen partnered with GHOST Lifestyle on the launch of GHOST® JOINT, featuring Unigen's clinically validated Univestin® ingredient for joint health support.
- DaVinci LaboratoriescoreDaVinci Laboratories launched Sleep Benefits™ Melatonin Free, containing Unigen's proprietary sleep ingredient Maizinol® as a novel melatonin-free formulation.
- Zuventus Healthcare Ltd (Healthyr-U brand)coreZuventus Healthcare launched Healthyr-U Anti-Acne & Hyperpigmentation cream in the Indian market in September 2023, using Bakutrol® as the key active ingredient. Distributed through online and pharmacy channels in India. Distributor: Viridis Personal Care.
- Vestrics Solutions Pvt LtdcoreVestrics Solutions (head office in Hyderabad, India) collaborated with Unigen on Phase I of the Phyto-AI™ project, an essential part of the PhytoLogix® technology platform. The collaboration migrated existing data from ORACLE-based NAPIS database, implemented and upgraded data collection, sort and analysis functions for the latest client environment. Vestrics is an SAP Gold Partner for SMEs globally. Dr. Qi Jia (CSO) expressed gratitude for Vestrics' exceptional acumen and unwavering support throughout the project.
- LEHVOSS NutritioncoreLEHVOSS Nutrition serves as Unigen's distributor for nutraceutical ingredients in Europe. LEHVOSS has followed Unigen's developments and scientific research in the USA over six years, serving as the right partner for European distribution. Quote from Teresita Rudà, Head of Brands and Marketing LEHVOSS Nutrition.
- Viridis BioPharmacoreViridis BioPharma is a techno-marketing organization based in Mumbai, India serving as Unigen's distributor for nutraceuticals in the Indian market. Viridis has been associated with Unigen for nearly a decade promoting and distributing botanically derived nutraceuticals. Managing Director Ashit Vora confirmed: 'Unigen's botanically derived, science driven skin and hair care active ingredients offer safe and efficacious solutions backed by extensive studies.'
- Science Based Ingredients (SBI)coreScience Based Ingredients (SBI) serves as Unigen's exclusive Canadian distributor for Univestin® and Maizinol® ingredients, distributing into the Canadian market.
- Viridis Personal CarecoreViridis Personal Care is a Mumbai-based distributor promoting Unigen Beauty cosmeceutical ingredients in the Indian market. Ashit Vora, Managing Director of Viridis BioPharma stated: 'Viridis is excited to bring these innovative solutions to the Indian market.'
- AyallasecondaryAyalla serves as Unigen's distributor for nutraceutical ingredients in Brazil (ayalla.com.br).
- CIC FrontiersecondaryCIC Frontier serves as Unigen's distributor for nutraceutical ingredients in Japan.
- CTC GroupsecondaryCTC Group serves as Unigen's distributor for nutraceutical ingredients in the Philippines.
- DaiwasecondaryDaiwa (daiwa-pharm.com) serves as Unigen's distributor for nutraceutical ingredients in Japan.
- MembrasecondaryMembra serves as Unigen's distributor for nutraceutical ingredients in Malaysia.
- PathwaysecondaryPathway serves as Unigen's distributor for nutraceutical ingredients in Australia.
- ChemphasecondaryChempha serves as Unigen's distributor for cosmeceutical ingredients.
- DeimossecondaryDeimos serves as Unigen's distributor for cosmeceutical ingredients in Italy.
- ElginsecondaryElgin serves as Unigen's distributor for cosmeceutical ingredients in Taiwan.
- IndelsecondaryIndel serves as Unigen's distributor for cosmeceutical ingredients in Ukraine.
- Lehvoss CosmeticssecondaryLehvoss Cosmetics serves as Unigen's distributor for cosmeceutical ingredients in Germany.
- ZealsecondaryZeal serves as Unigen's distributor for cosmeceutical ingredients in China.
Scale indicators2 records
Recent moves6 records
Expansion highlights6 records
Unigen competitors and assessment
Company assessmentDirect peers
- Sabinsa: Sabinsa is a leading manufacturer of patented, clinically validated botanical extracts for nutraceutical, cosmeceutical, and pharmaceutical applications — directly comparable to Unigen's PhytoLogix®-driven ingredient model across similar end-markets and customer base.
- Indena S.p.A. Indena is an Italian botanical extracts manufacturer supplying standardized, clinically tested actives to the nutraceutical, cosmetic, and pharmaceutical industries — a direct peer in proprietary botanical ingredients with similar B2B licensing and supply-alliance model.
- Euromed: Euromed produces standardized botanical and fruit extracts for the nutraceutical and pharmaceutical markets, with strong emphasis on clinical evidence — comparable to Unigen in serving brand manufacturers with patented, scientifically backed ingredients.
- Nexira: Nexira supplies plant-based functional and nutritional ingredients to nutraceutical and cosmetic brands globally — overlapping with Unigen in botanical actives, B2B supply alliances, and the cosmeceutical category.
- BioActives LLC: BioActives develops and manufactures proprietary, clinically supported botanical ingredients for dietary supplement, food, and beverage applications — a focused mid-size peer with a similar patented-ingredient licensing model to Unigen.
- Pharmachem Laboratories: Pharmachem supplies branded, clinically researched nutraceutical and functional food ingredients to global brand manufacturers — comparable to Unigen in serving the same B2B customer base with proprietary, science-backed botanical actives.
- Bio-Botanica: Bio-Botanica manufactures standardized botanical extracts for the cosmetic, personal care, and nutraceutical industries — an overlapping peer in Unigen's cosmeceutical and nutraceutical verticals with similar B2B ingredient supply dynamics.
Broad incumbents
- Givaudan (Naturex): Givaudan acquired Naturex to build a leading natural ingredients platform spanning flavors, fragrances, and botanical extracts — competing with Unigen across nutraceutical and cosmeceutical categories as a much larger incumbent with greater R&D and commercial scale.
- Kemin Industries: Kemin is a privately held ingredient manufacturer with extensive botanical and nutritional ingredient lines serving human and animal nutrition — a broad incumbent competing with Unigen in nutraceuticals and the pet/animal health space.
- ADM (Health & Wellness / Wild Flavors): ADM's Health & Wellness unit (incorporating Wild Flavors) supplies plant-based extracts, flavors, and functional ingredients to nutraceutical and food customers — a broad incumbent with significantly larger R&D, manufacturing, and global distribution than Unigen.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
Unigen social profiles
Digital presenceUnigen financial estimates
Financial estimateRevenue estimate
Valuation estimate
Unigen leadership team
Management profileNumber of profiles
Profiles7 records
Unigen funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Unigen M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Unigen
What does Unigen do?
Unigen develops proprietary patented botanical extracts through its PhytoLogix® research platform and commercializes them as branded ingredients to B2B manufacturers across three product lines: Nutraceuticals (human dietary supplement actives), Cosmeceuticals (skin and hair care actives), and Pet Health (companion animal wellness actives). Ingredients are clinically validated, manufactured to GMP standards, protected by issued patents in all major territories, and supplied under licensing and ingredient supply alliances to commercial partners that formulate finished consumer products.
Is Unigen a public or private company?
Unigen is a private company. It is classified as management employee owned and is currently operating.
When was Unigen founded?
Unigen was founded in 1996. It employs 101 to 250 people.
Where is Unigen based?
Unigen is headquartered in Tacoma, United States, in the North America region.
How does Unigen make money?
Two revenue lines are on record. Ingredient Licensing and Supply is the primary driver. The others are ingredient Supply Agreements.
Who are Unigen's main competitors?
Direct peers on record are Sabinsa, Indena S.p.A., Euromed, Nexira, BioActives LLC, Pharmachem Laboratories and Bio-Botanica. Broad incumbents are Givaudan (Naturex), Kemin Industries and ADM (Health & Wellness / Wild Flavors).
Does Unigen have an API?
No public API is recorded for Unigen.
What industry is Unigen in?
Unigen's product category is Botanical Ingredients. Its primary akta.pro industry code is CRADAGAD, Herbal & Botanical Supplements, with a secondary code of AFAJADAB, Natural Extracts & Essential Oils (Botanical/Citrus/Herb/Spice Extracts). Its NAICS code is 325411 and its SIC code is 2833.